Christopher Rovaldi

Companies

• Keros Therapeutics, Inc.Chief operating officer Feb 3, 2022 to now¹
• Acceleron PharmaSVP, Program Mgmt and Ops May 8, 2017 to Apr 4, 2018²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• KTKeros Therapeutics, Inc. KROS60,000 shares³$666.0K at $11.10Feb 18, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

• Feb 18, 2025Granted 60,000 shares of Keros Therapeutics, Inc.³
• Apr 6, 2022Sold 1,728 shares at $65.00 of Keros Therapeutics, Inc.⁴
• Apr 6, 2022Exercised options 1,728 shares at $16.00 of Keros Therapeutics, Inc.⁴
• Apr 1, 2022Sold 105 shares at $58.83 of Keros Therapeutics, Inc.⁵
• Apr 1, 2022Sold 366 shares at $57.97 of Keros Therapeutics, Inc.⁵
• Apr 1, 2022Sold 287 shares at $56.89 of Keros Therapeutics, Inc.⁵
• Apr 1, 2022Sold 104 shares at $56.20 of Keros Therapeutics, Inc.⁵
• Apr 1, 2022Sold 2 shares at $54.34 of Keros Therapeutics, Inc.⁵
• Apr 1, 2022Exercised options 864 shares at $16.00 of Keros Therapeutics, Inc.⁵